(Encephalopathy, Hepatic; Portal-Systemic Encephalopathy; Encephalopathy, Portal-Systemic)
Pronounced: HEP-at-ik En-SEF-a-lo-PATH-ee
by Nathalie Smith, MSN, RN
Hepatic encephalopathy is a problem with the brain that is caused by liver disease. The problem may be temporary or permanent.
A liver with disease cannot filter the harmful items in blood. These toxins build up in the blood, which reaches the brain and affects the brain’s ability to work properly.
Risk Factors TOP
Factors that increase your chance of hepatic encephalopathy include:
In the early stages, you may not notice any symptoms. As the condition progresses, symptoms may include:
If you have liver problems and any of the above symptoms, call your doctor right away.
You will be asked about your symptoms and medical history. A physical exam will be done. The condition of your nervous system will also be assessed.
Your liver and kidney function may be assessed. This can be done with:
Your brain and nervous system may be assessed. This can be done with:
Hospitalization and Emergency Care
The initial treatment will focus on treating and trying to reverse the underlying problems. If possible, toxins in your blood will be removed or neutralized.
Medications may be used to:
Dietary Restrictions TOP
Changes in your diet may be recommended. Tube feeding may be needed to supply nutrients, especially in the case of coma.
To help reduce your chance of hepatic encephalopathy:
National Digestive Diseases Information Clearinghouse
National Institute of Neurological Disorders and Stroke
Bernuau J. Acute liver failure: Avoidance of deleterious co-factors and early specific medical therapy for the liver are better than late intensive care for the brain. J Hepatol. 2004;41:152-155.
Butterworth RF. Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices. Liver Int. 2003;23(suppl 3):5-9.
Hepatic encephalopathy. Canadian Liver Foundation website. Available at: https://www.liver.ca/patients-caregivers/liver-diseases/hepatic-encephalopathy/. Accessed February 14, 2018.
Hepatic encephalopathy. Cleveland Clinic website. Available at:
...(Click grey area to select URL)
Updated August 2017. Accessed February 14, 2018.
Hepatic encephalopathy. EBSCO DynaMed Plus website. Available at: http://www.dynamed... . Updated November 1, 2016. Accessed February 14, 2018.
Liere V, Sandhu G, DeMorrow S. Recent advances in hepatic encephalopathy. F1000Res. 2017;6:1637.
Lizardi-Cervera J, Almeda P, Guevara L, et al. Hepatic encephalopathy: a review. Ann Hepatol. 2003;2:122-130.
Toftengi F, Larsen F. Management of patients with fulminant hepatic failure and brain edema. Metab Brain Dis. 2004;19:207-214.
4/2/2010 DynaMed Plus Systematic Literature Surveillance http://www.dynamed...: FDA approves new use of Xifaxan for patients with liver disease. US Food and Drug Administration website. Available at:
...(Click grey area to select URL)
Updated April 24, 2013. Accessed February 17, 2014.
Last reviewed March 2018 by EBSCO Medical Review Board Rimas Lukas, MD
Last Updated: 3/5/2014
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.